Evaluation of the Developmental Toxicity of Vedolizumab, an α<sub>4</sub>β<sub>7</sub> Receptor Antagonist, in Rabbit and Nonhuman Primate.

Int J Toxicol · 2019 · PMC6749749 · PMID 31364424

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Exposure of vedolizumab showed an increasing trend in a greater than dose proportional manner.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.